[Early versus late hormonal treatment in advanced prostate cancer]
- PMID: 10488608
[Early versus late hormonal treatment in advanced prostate cancer]
Similar articles
-
Effectiveness of Maximal Androgen Blockade (MAB): illusion or reality?Can J Urol. 2005 Feb;12 Suppl 1:77-80. Can J Urol. 2005. PMID: 15780172 Review.
-
[Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].Vopr Onkol. 1998;44(5):537-40. Vopr Onkol. 1998. PMID: 9884710 Review. Russian.
-
Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.Cancer. 2009 Aug 1;115(15):3376-8. doi: 10.1002/cncr.24393. Cancer. 2009. PMID: 19484788 No abstract available.
-
[Castration of prostate cancer patients and cognition].Duodecim. 2005;121(16):1784-5. Duodecim. 2005. PMID: 16268226 Review. Finnish. No abstract available.
-
Hormone-refractory prostate cancer: what have we learned?BJU Int. 2007 Jul;100 Suppl 2:56-9. doi: 10.1111/j.1464-410X.2007.06957.x. BJU Int. 2007. PMID: 17594362 Review. No abstract available.
Cited by
-
Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.Cochrane Database Syst Rev. 2019 Jun 11;6(6):CD003506. doi: 10.1002/14651858.CD003506.pub2. Cochrane Database Syst Rev. 2019. PMID: 31194882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical